The short answer is that stem cell therapy works for some medical conditions, may help selected patients in other areas, and remains unproven for many claims found online. The outcome depends on the type of stem cell, the condition being treated, the quality of the cellular product, the delivery method, and the individual patient.
This is why asking whether stem cells work is similar to asking whether medication works. There is no single answer because different products are used for different medical purposes.
Stem Cell Therapy Is Not One Treatment
he term stem cell therapy covers several different types of cells and medical procedures.
Blood-forming stem cells have been used for decades in bone marrow and cord blood transplantation. These treatments are established for certain blood cancers, immune disorders, and bone marrow diseases.
Mesenchymal stromal cellsor stem cells, commonly called MSCs, are different. They may be obtained from bone marrow, fat tissue, placenta, or umbilical cord tissue. MSCs are being investigated in orthopedics, neurology, autoimmune disease, and other areas of regenerative medicine.
These applications do not all have the same level of clinical evidence. A result involving one cell type or medical condition cannot automatically be applied to another.
UC-MSCs are derived from umbilical cord tissue and are different from the blood-forming stem cells found in umbilical cord blood. UC-MSCs are studied in regenerative medicine for their biological signaling and immunomodulatory properties, while cord blood stem cells are primarily used in established treatments for certain blood, bone marrow, and immune disorders.
How Do MSCs Work?
MSCs were once expected to travel into damaged tissue and permanently become replacement cells. Current research suggests that their main effects are more likely to come from biological signaling.
MSCs release growth factors, cytokines, and extracellular vesicles that interact with immune cells and surrounding tissues. These signals may help regulate inflammation, support blood vessels, reduce cellular stress, and influence the environment involved in tissue repair.
These biological mechanisms help explain why MSCs are being investigated across different areas of regenerative medicine. However, the clinical response varies between patients and conditions, and the degree of benefit cannot be predicted from biological mechanisms alone
Where Is the Evidence Most Encouraging?
Knee Osteoarthritis
Knee osteoarthritis is one of the most extensively studied applications of MSC therapy.
Systematic reviews of randomized clinical studies suggest that MSC injections may improve pain and physical function in some patients with knee osteoarthritis. However, outcomes vary considerably between studies because researchers use different cell sources, doses, processing methods, injection protocols, and patient groups.
The evidence for symptom improvement is more developed than the evidence for cartilage regrowth. Patients should therefore be cautious about claims that stem cell injections will rebuild an entire joint or reverse advanced bone-on-bone arthritis.
For selected patients, MSC therapy may be considered as part of a joint preservation plan. It should not be presented as a guaranteed replacement for physiotherapy, medication, weight management, or surgery when structural damage requires surgical treatment.
Sports Injuries and Tendon Conditions
MSCs are also being studied for tendon injuries, cartilage damage, and other musculoskeletal problems. Early findings are scientifically interesting, but the evidence is less consistent than it is for knee osteoarthritis.
The location and severity of the injury matter. A biological injection cannot mechanically repair every complete tendon tear, unstable joint, severe deformity, or advanced structural injury.
This is why imaging and orthopedic assessment are important before treatment is recommended.
Neurological Conditions
Research is evaluating MSC therapy for stroke, spinal cord injury, multiple sclerosis, Parkinson’s disease, and other neurological conditions.
Some studies have reported acceptable safety findings and possible changes in functional measurements. However, the overall evidence remains difficult to interpret. Studies use different cell products, administration routes, rehabilitation programs, and outcome measures.
MSC therapy has not been established as a cure for neurodegenerative disease and has not been shown to replace lost neurons reliably. In neurological care, it is more appropriate to describe MSC therapy as an investigational or supportive approach considered in selected cases.
Standard neurological treatment and rehabilitation remain essential.
Systemic and Autoimmune Conditions
MSCs are being studied for their immunomodulatory properties in autoimmune disease, kidney disease, diabetes, and other systemic conditions.
Laboratory findings and early clinical research provide reasons for continued investigation, but evidence of a possible biological effect is not the same as proof of lasting clinical improvement. These conditions are medically complex and usually require continued care from the relevant specialist.
Why Do Results Differ Between Patients?
Even when research suggests a possible benefit, two patients may respond differently.
Important factors include:
- The correct diagnosis
- Disease severity and duration
- Age and general health
- Previous treatments
- Cell source and manufacturing quality
- Cell identity, sterility, viability, and dose
- Local injection, intravenous infusion, or another delivery route
- Rehabilitation and follow-up care
- The outcome used to measure improvement
A patient may report less pain while an MRI shows little structural change. Another patient may experience better movement without complete symptom resolution. These outcomes can still be meaningful, but they should be described accurately.
What Does a Realistic Result Look Like?
A realistic treatment goal should be linked to the patient’s condition.
For a patient with knee osteoarthritis, a meaningful outcome might include less pain, improved walking tolerance, better function, or reduced reliance on pain medication.
For a patient recovering from stroke, goals may include supporting rehabilitation, maintaining function, or improving a specific ability. Stem cell therapy should not be described as restoring the brain or guaranteeing neurological recovery.
Treatment success should be assessed using measurable outcomes rather than general statements such as feeling younger or experiencing complete regeneration.
Does Cell Quality Matter?
Yes. MSC products can differ substantially even when clinics use similar names for them.
Relevant quality factors include donor screening, laboratory conditions, sterility testing, cell identity, viability, passage number, storage, transportation, and preparation before administration.
However, a high-quality cellular product does not guarantee that the treatment will work. Product quality helps reduce avoidable uncertainty, while clinical effectiveness also depends on whether the treatment is appropriate for the condition and patient.
The Importance of Medical Selection
Responsible regenerative medicine begins with diagnosis and patient selection, not with selling a predetermined number of cells.
For orthopedic conditions, this may require examination and review of an X-ray or MRI. For neurological conditions, the doctor may need to consider diagnosis, disease stage, current function, medications, rehabilitation history, and overall health.
Some patients may be suitable candidates. Others may benefit more from physiotherapy, medication, surgery, rehabilitation, or another established treatment.
A clinic that recommends an alternative when stem cell therapy is unlikely to help is making a medical decision, not withholding treatment.
So, Does Stem Cell Therapy Work?
Stem cell therapy is not one universal treatment. Blood-forming stem cell transplantation is established for specific diseases. MSC therapies show encouraging potential in selected areas, particularly for symptoms and function in knee osteoarthritis, but evidence varies across conditions.
The most responsible answer is neither that stem cells never work nor that they can regenerate everything. The answer depends on the medical indication, the product, the treatment protocol, and the patient.
Patients considering stem cell therapy in Bangkok or elsewhere should receive a specialist evaluation, a clear explanation of the evidence, realistic treatment goals, and appropriate follow-up care.
About EDNA Wellness
EDNA Wellness is a surgeon-led regenerative medicine center in Bangkok, specializing in orthopedic and neurological conditions using Umbilical Cord-Derived Mesenchymal Stem Cells (UC-MSCs).
All cases are reviewed by orthopedic surgeons and neurosurgeons, with a focus on clinical indication, patient safety, and realistic treatment expectations. Stem cell therapy is recommended selectively, and alternative treatments are considered when more appropriate.
For more information or to book a consultation:
LINE: @ednawellness
WhatsApp: +66 (0) 64 505 5599
www.ednawellness.com
References
- Cao M, et al. Efficacy and Safety of Mesenchymal Stem Cells in Knee Osteoarthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Stem Cell Res Ther. 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC11887158/
- Patel GD, et al. Mesenchymal Stem Cell-Based Therapies for Treating Well-Studied Neurological Disorders: A Systematic Review. Front Med. 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC11004389/
- International Society for Stem Cell Research. The ISSCR Guide to Stem Cell Treatments. ISSCR. 2026. https://www.isscr.org/treatment-guide
- U.S. Food and Drug Administration. Important Patient and Consumer Information About Regenerative Medicine Therapies. FDA. 2021. https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/important-patient-and-consumer-information-about-regenerative-medicine-therapies